A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing–remitting multiple sclerosis

Background: Mycophenolate mofetil (MMF, CellCept®) has been utilized as an antirejection agent in transplant recipients and in patients with myriad autoimmune disorders including multiple sclerosis (MS). Objective: To investigate radiographic and clinical safety involving monotherapy use of daily or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Frohman, Elliot M., Cutter, Gary, Remington, Gina, Gao, Hongjiang, Rossman, Howard, Weinstock-Guttman, Bianca, Durfee, Jacqueline E., Conger, Amy, Carl, Ellen, Treadaway, Katherine, Lindzen, Eric, Salter, Amber, Frohman, Teresa C., Shah, Anjali, Bates, Angela, Cox, Jennifer L., Dwyer, Michael G., Stüve, Olaf, Greenberg, Benjamin M., Racke, Michael K., Zivadinov, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2010
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3002613/
https://ncbi.nlm.nih.gov/pubmed/21180633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285609353354
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados